Enzyme replacement therapy (ERT) can effectively manage lysosomal storage diseases, but it may cause hypersensitivity reactions in some patients.
A study reviewed medical records of pediatric patients to assess the frequency and characteristics of these allergic reactions, finding that 25.3% experienced them, with anaphylaxis occurring in 6 cases.
Management of hypersensitivity may include premedication and slower infusions, and some patients may require desensitization protocols to continue ERT safely.